Abstract
The human hematopoietic stem cell compartment is comprised of repopulating CD34+ and CD34− cells. The interaction between these subsets with respect to their reconstitution capacity in vivo remains to be characterized. Here, lineage-depleted (Lin−) human CD34+ and CD34− hematopoietic cells were isolated from human male and female umbilical cord blood (CB) and transplanted into immune-deficient NOD/SCID EMVnull mice, thereby allowing the use of human and Y-chromosome-specific DNA sequences to discriminate human reconstitution contributed by CD34+ vs CD34− repopulating stem cells. Although cultured human CB CD34−Lin− cells transplanted alone possessed only minimal repopulating capacity, with 15% of mice achieving low levels of engraftment, transplantation of cocultured male CD34−Lin− cells with female CD34+Lin− cells demonstrated human repopulation with a contribution from CD34−Lin−-derived progeny in 80% of the recipients. After coculture and transplantation, male CD34−Lin− cells gave rise to primitive CD34+CD38− cells isolated in vivo, which demonstrated clonogenic progenitor function into multiple lineages. Taken together, our study indicates that the presence of CD34+Lin− cells in coculture enhanced the low repopulating function of human CD34−Lin− cells in vivo. We propose that CD34+Lin and CD34−Lin cells represent phenotypically distinct, but related cell types that exhibit unique and previously unappreciated functional interaction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 1988; 81: 951–955.
Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH . Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157–165.
Civin CI, Trischmann T, Kadan NS, Davis J, Noga S, Cohen K et al. Highly purified CD34−positive cells reconstitute hematopoiesis. J Clin Oncol 1996; 14: 2224–2233.
Dao MA, Nolta JA . CD34: to select or not to select? That is the question. Leukemia 2000; 14: 773–776.
Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE . Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997; 94: 5320–5325.
Dick JE, Bhatia M, Gan O, Kapp U, Wang JC . Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 1997; 15 (Suppl. 1): 199–203.
Larochelle A, Vormoor J, Hanenberg H, Wang JC, Bhatia M, Lapidot T et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996; 2: 1329–1337.
Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE . A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038–1045.
Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC . Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797–1806.
Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997; 3: 1337–1345.
Osawa M, Hanada K, Hamada H, Nakauchi H . Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273(5272): 242–245.
Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M . Human bone marrow CD34− cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998; 26: 353–360.
Zhao Y, Lin Y, Zhan Y, Yang G, Louie J, Harrison DE et al. Murine hematopoietic stem cell characterization and its regulation in BM transplantation. Blood 2000; 96: 3016–3022.
Sato T, Laver JH, Ogawa M . Reversible expression of CD34 by murine hematopoietic stem cells. Blood 1999; 94: 2548–2554.
Prochazka M, Gaskins HR, Shultz LD, Leiter EH . The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 1992; 89: 3290–3294.
Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new ‘speed congenic’ stock of NOD.Ig mu null mice. J Exp Med 1996; 184: 2049–2053.
Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE . Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997; 186: 619–624.
Hogan CJ, Shpall EJ, McNulty O, McNiece I, Dick JE, Shultz LD et al. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997; 90: 85–96.
Arnemann J, Epplen JT, Cooke HJ, Sauermann U, Engel W, Schmidtke J . A human Y-chromosomal DNA sequence expressed in testicular tissue. Nucleic Acids Res 1987; 15: 8713–8724.
Mangioni S, Balduzzi A, Rivolta A, Rovelli A, Nesi F, Rossi V et al. Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation. Bone Marrow Transplant 1997; 20: 969–973.
Wang JC, Doedens M, Dick JE . Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89: 3919–3924.
Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994; 83: 2489–2497.
Serreze DV, Leiter EH, Hanson MS, Christianson SW, Shultz LD, Hesselton RM et al. Emv30null NOD-scid mice. An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 1995; 44: 1392–1398.
Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M . Isolation and characterization of human CD34(−)Lin(−) and CD34(+)Lin(−) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813–2820.
Guenechea G, Gan OI, Inamitsu T, Dorrell C, Pereira DS, Kelly M et al. Transduction of human CD34+ CD38− bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol Ther 2000; 1: 566–573.
Dao MA, Arevalo J, Nolta JA . Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 2003; 101: 112–118.
Karanu FN, Gallacher L, Bhatia M . Differential response of primitive human CD34neg and CD34pos hematopoietic cells to the Notch ligand Jagged-1. Leukemia 2003 (in press).
Martinez C, Urbano-Ispizua A, Rozman C, Marin P, Rovira M, Sierra J et al. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Exp Hematol 1999; 27: 561–568.
Harrison DE, Astle CM . Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: models for human umbilical cord blood. Blood 1997; 90: 174–181.
Link H, Arseniev L, Bahre O, Kadar JG, Diedrich H, Poliwoda H . Transplantation of allogeneic CD34+ blood cells. Blood 1996; 87: 4903–4909.
Peters C, Matthes-Martin S, Fritsch G, Holter W, Lion T, Witt V et al. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 1999; 13: 2070–2078.
Schiller G, Vescio R, Freytes C, Spitzer G, Lee M, Wu CH et al. Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma. Bone Marrow Transplant 1998; 21: 141–145.
Acknowledgements
Support for this research project was provided by a grant from the Multiple Organ Transplant Initiative, London Health Sciences Center, the Ontario Research and Development Challenge Fund in Xenotransplantation and the Canadian Institute of Health Research (CIHR) and a Canada Research Chair in Stem Cell Biology and Regenerative Medicine to M Bhatia, and a postdoctoral fellowship award from the CIHR for D Hess. In addition, we wish to recognize the technical assistance of Barbara Murdoch towards the completion of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hess, D., Karanu, F., Levac, K. et al. Coculture and transplant of purified CD34+Lin− and CD34−Lin− cells reveals functional interaction between repopulating hematopoietic stem cells. Leukemia 17, 1613–1625 (2003). https://doi.org/10.1038/sj.leu.2403028
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403028
Keywords
This article is cited by
-
Cell therapy in end-stage liver disease: replace and remodel
Stem Cell Research & Therapy (2023)
-
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts
Bone Marrow Transplantation (2019)
-
Contribution of human hematopoietic stem cells to liver repair
Seminars in Immunopathology (2009)
-
Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD/SCID mice
Bone Marrow Transplantation (2005)
-
Adult stem cells and cancer stem cells: tie in or tear apart?
Journal of Cancer Research and Clinical Oncology (2005)